Logo-jrhs
J Res Health Sci. 2021;21(3): e00525. doi: 10.34172/jrhs.2021.58
PMID: 34698659        PMCID: PMC8957684

Original Article

Effects of Lifestyle and Environmental Factors on the Risk of Acute Myeloid Leukemia: Result of a Hospital-based Case-Control Study

Masumeh Maleki Behzad, Mohammad Abbasi, Iman Oliaei, Somayeh Ghorbani Gholiabad, Hassan Rafieemehr *

Cited by CrossRef: 5

1- Korbecki J, Bosiacki M, Kupnicka P, Barczak K, Chlubek D, Baranowska-Bosiacka I. CXCR4 as a therapeutic target in acute myeloid leukemia. Leukemia. 2024;38(11):2303 [Crossref]
2- Hirasaki Y, Okabe A, Fukuyo M, Rahmutulla B, Mano Y, Seki M, Hoshii T, Namiki T, Kaneda A. Cinobufagin inhibits proliferation of acute myeloid leukaemia cells by repressing c-Myc pathway-associated genes. Chemico-Biological Interactions. 2022;360:109936 [Crossref]
3- Li L, Han C, Yu X, Shen J, Cao Y, Abdulhay E. Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis. Journal of Healthcare Engineering. 2022;2022:1 [Crossref]
4- Zerella J, Homan C, Arts P, Brown A, Scott H, Hahn C. Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy. Front Oncol. 2023;13 [Crossref]
5- Motahari F, Karampourian A, Rafieemehr H. Different Mechanisms of Cancer Drug Resistance: A Brief Review. Avicenna J Care Health Oper Room. 2023;1(2):68 [Crossref]
6- Qasim Mohammed M, Hussein Alwan A, Amer Almukhtar A, Kareem Aneed Al-Saedi M. Revealing of TLR-9 gene polymorphisms by qPCR HRM technique and their influence on TLR-9 serum level in acute myeloid leukemia patients: Case-control study. Cytokine. 2024;182:156730 [Crossref]
7- Mtashar B, Ashoor Z, Shabeeb Z, Matti B. Assessment of Soluble Natural Killer Group 2d Ligand (MHC Class I A and UL16 Binding Protein 1) in Iraqi Patients with Acute Myeloid Leukemia. 2022;21(2):171 [Crossref]